300750.SZ (300750.SZ)

$1.84T
Market Cap
24.9
P/E Ratio
0.72
Beta
1.35%
Dividend Yield
Piotroski 6/9Altman Z 3.1 SafeROIC−WACC +3.6%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 3.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency demonstrates a robust spread between the cost of equity and return on invested capital, with an ROIC-WACC differential of +3.6% indicating value creation potential above the hurdle rate. This performance is underpinned by strong profitability drivers; a net margin of 17.0% coupled with revenue growth matching that expansion at 17.0% suggests pricing power and operational leverage are functioning in tandem, while gross margins sit comfortably at 26.3%. Solvency and financial strength metrics further support this quality profile, as evidenced by an Altman Z-Score of 3.1 signaling a low probability of distress, complemented by a Piotroski F-Score of 6/9 that reflects solid fundamental health relative to peers.

Valuation multiples currently stand at 24.9x trailing earnings, which requires contextualization against historical norms and sector averages to determine if the premium is justified or stretched. From an intrinsic value perspective, a DCF model calculates a fair value of $875; however, without knowing the current market price per share, it remains unclear whether the stock trades at a discount, parity, or significant premium relative to this calculated anchor. The market's pricing appears to embed specific growth assumptions that must be weighed against the implied trajectory required to sustain the observed 17% revenue expansion and margin profile over time.

While no risk factor deltas, insider activity data, or Fama-French alpha figures were provided in the input dataset, a complete assessment of downside protection would typically require analyzing these additional dimensions alongside the existing profitability and solvency metrics. The absence of such volatility measures means the current teardown relies primarily on fundamental quality and valuation gaps rather than relative risk-adjusted returns or behavioral market anomalies to form a comprehensive view of the investment case.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →7.1%9.1%11.1%
2%$1085$775$603
3%$1309$875$658
4%$1678$1015$727

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=9.1%, terminal growth 3%. Fair value $875 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
3.1
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

26.3%
Gross Margin
17.0%
Net Margin
12.7%
ROIC
9.1%
WACC
ROIC − WACC Spread: +3.6%— Positive spread.
+17.0%
Revenue Growth (YoY)
+42.3%
Earnings Growth (YoY)
90.9B
Free Cash Flow
36%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.63x
Debt / Equity
1.60x
Current Ratio
33.7x
Interest Coverage
-2.1x
Net Debt / EBITDA
5.73%
FCF Yield
117.4B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $2.55
Act: $2.69
+5.6%
Q3
✓ Beat
Est: $3.27
Act: $3.48
+6.3%
Q2
✗ Miss
Est: $3.68
Act: $3.63
-1.5%
Q1
✓ Beat
Est: $4.01
Act: $4.62
+15.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.9
Forward P/E
PEG Ratio
5.42
Price/Book
32M
Avg Volume
$424.36
52W High
$209.11
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in 300750.SZ to visualize passive redemption contagion across ETFs and collateral stocks.

300750.SZ Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
300750.SZEpicenterLITETFRIOLow Risk006400.KSUnknownALBMed Risk6752.TMed Risk002460.SZMed Risk
300750.SZ Price Drop (%)0

If 300750.SZ (300750.SZ) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Rio Tinto PLC ADR (RIO) as the most exposed collateral stock, sharing 1 ETFs with 300750.SZ. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

300750.SZ Ownership Dynamics

Ticker
300750.SZ

ETFs with Highest 300750.SZ Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

300750.SZ Capital Efficiency

How efficiently does 300750.SZ convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$90.9B
EBITDA
$117.4B
FCF Conversion
77%
Reinvestment Rate
23%
77% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
12.7%
ROIC − WACC Spread
3.6%

300750.SZ converts 77% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 3.6% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare 300750.SZ to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.